Published in Clin Neurophysiol on June 19, 2008
Primary dystonia: molecules and mechanisms. Nat Rev Neurol (2009) 1.51
The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain (2011) 1.44
Primary dystonia: moribund or viable. Mov Disord (2013) 0.82
Advances in the genetics of primary torsion dystonia. F1000 Biol Rep (2010) 0.80
Limb amputations in fixed dystonia: a form of body integrity identity disorder? Mov Disord (2011) 0.79
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med (1999) 3.69
A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med (1998) 3.19
Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol (1999) 2.89
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol (2011) 2.63
A new stress-related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiency. Lancet (1996) 2.58
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system. Arch Dis Child (1992) 2.17
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology (2011) 2.10
A new method for autozygosity mapping using single nucleotide polymorphisms (SNPs) and EXCLUDEAR. J Med Genet (2004) 2.02
Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology (2007) 1.90
Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol (1995) 1.79
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet (2001) 1.72
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol (2009) 1.70
Multiple sclerosis associated with duplicated CMT1A: a report of two cases. J Neurol Neurosurg Psychiatry (1997) 1.67
Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology (1999) 1.66
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
Anterior speech region. Asymmetry and weight-surface correlation. Arch Neurol (1989) 1.61
Botulinum toxin for chronic anal fissure. Lancet (1994) 1.61
Analysis of blink rate patterns in normal subjects. Mov Disord (1997) 1.57
Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurol Scand (1997) 1.57
Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology (2003) 1.57
Zolpidem in Parkinson's disease. Lancet (1997) 1.57
Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet (1995) 1.54
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs. Dysport" controlled trial. Aliment Pharmacol Ther (2004) 1.53
Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis. Neuropediatrics (2007) 1.53
Bilateral contemporaneous posteroventral pallidotomy for the treatment of Parkinson's disease: neuropsychological and neurological side effects. Report of four cases and review of the literature. J Neurosurg (1999) 1.52
Dural arteriovenous fistulas with aggressive course: clinical and angiographic correlations in two patients. Neurol Sci (2005) 1.51
Somatosensory disinhibition in dystonia. Mov Disord (2001) 1.50
NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. J Med Genet (2005) 1.47
White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol (2009) 1.46
Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology (2003) 1.45
Modelling hemodynamic response function in epilepsy. Clin Neurophysiol (2013) 1.45
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.44
Botulinum toxin treatment of painful tonic spasms in multiple sclerosis. Neurology (2003) 1.43
[Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers]. Med Lav (2008) 1.41
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. Eur J Neurol (2014) 1.41
Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry (1996) 1.41
Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation. Neurology (2007) 1.40
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Eur J Neurol (2009) 1.39
Autosomal recessive severe dwarfism in a Sicilian girl: a new form of osteodysplastic primordial dwarfism? Am J Med Genet (1996) 1.39
Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years. Eur J Neurol (2014) 1.39
Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology (1999) 1.37
Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet (1996) 1.36
A locus for autosomal dominant keratoconus maps to human chromosome 3p14-q13. J Med Genet (2004) 1.36
Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.31
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. Neurology (1999) 1.31
Motor disinhibition in affected and unaffected hemisphere in the early period of recovery after stroke. Clin Neurophysiol (2002) 1.29
Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol (1998) 1.25
Diffusion tensor imaging in Joubert syndrome. AJNR Am J Neuroradiol (2007) 1.25
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol (1999) 1.23
Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease. J Neurol Neurosurg Psychiatry (1984) 1.22
Inhibitory action of forearm flexor muscle afferents on corticospinal outputs to antagonist muscles in humans. J Physiol (1998) 1.16
Correlation between cortical plasticity, motor learning and BDNF genotype in healthy subjects. Exp Brain Res (2011) 1.16
Respiratory symptoms at age 8 years in a cohort of very low birth weight children. Am J Epidemiol (2001) 1.16
Somatosensory temporal discrimination in patients with primary focal dystonia. J Neurol Neurosurg Psychiatry (2009) 1.15
Observations on the sensory nature of the intramuscular nerve action potential. J Neurol Neurosurg Psychiatry (1973) 1.14
Neurological research in Italy in 2003 and 2004. Neurol Sci (2005) 1.13
Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease. J Neurol Neurosurg Psychiatry (1986) 1.13
Suprascapular nerve entrapment. Neurophysiological localization in 6 cases. Acta Orthop Scand (1996) 1.13
A family study on primary blepharospasm. J Neurol Neurosurg Psychiatry (2006) 1.13
Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology (2002) 1.13
Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology (2008) 1.10
Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am J Pathol (1999) 1.10
Camptocormia in Parkinson disease: an epidemiological and clinical study. J Neurol Neurosurg Psychiatry (2008) 1.10
Motor cortical disinhibition during early and late recovery after stroke. Neurorehabil Neural Repair (2008) 1.09
Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry (1998) 1.09
Tactile temporal discrimination in patients with blepharospasm. J Neurol Neurosurg Psychiatry (2007) 1.09
Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Ann N Y Acad Sci (2005) 1.08
Preferential maternal derivation in inv dup(15): analysis of eight new cases. Hum Genet (1981) 1.08
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Nephronophthisis type 1 deletion syndrome with neurological symptoms: prevalence and significance of the association. Kidney Int (2006) 1.06
Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study. J Neurol Neurosurg Psychiatry (2006) 1.06
Abnormal central integration of a dual somatosensory input in dystonia. Evidence for sensory overflow. Brain (2000) 1.06
Transient inhibition of the human motor cortex by capsaicin-induced pain. A study with transcranial magnetic stimulation. Neurosci Lett (2001) 1.05
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study. Ital J Neurol Sci (1982) 1.04
PINK1 protects against cell death induced by mitochondrial depolarization, by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage. Cell Death Differ (2013) 1.04
Cognitive and behavioural effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 1.03
RPGRIP1L mutations are mainly associated with the cerebello-renal phenotype of Joubert syndrome-related disorders. Clin Genet (2008) 1.03
Neuroimmunology of gangliosides in human neurons and glial cells in culture. J Neurosci Res (1986) 1.03
Temporal discrimination of somesthetic stimuli is impaired in dystonic patients. Neuroreport (1999) 1.02